静脉血栓症中的代谢景观:对分子生物学和治疗影响的见解
Zheng Cao1,2,3, Xuejun Jiang1,2,3, Yiyu He1,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Annals of medicine
|September 19, 2024
概括
炎症和代谢变化导致静脉血栓形成,特别是在癌症中. 针对这些途径提供了减少血栓形成风险的新策略.
科学领域:
- * 心血管医学 * 心血管医学
- * 瘤学 瘤学是一门专业.
- * 代谢研究研究
背景情况:
- *静脉血栓症涉及炎症细胞,凝血和血小板激活之间的复杂相互作用.
- *各种细胞中的代谢途径 (葡萄糖,脂质,同素,氧化应激) 与静脉血栓形成的炎症有关.
- *代谢微环境的改变与癌症血栓形成风险有关.
研究的目的:
- * 审查在驱动血栓性疾病中代谢和血栓形成之间的协同关系.
- * 探索抗炎策略在控制静脉血栓形成方面的潜力.
- * 检查在血栓性疾病中抗炎和代谢之间的相互作用.
主要方法:
- *对新陈代谢,炎症和血栓形成的最新发现进行了全面的文献综述.
- *分析细胞和分子机制,将代谢途径与血栓形成过程联系起来.
- * 对静脉血栓形成的抗炎和代谢干预措施的探索.
主要成果:
- *代谢变化与静脉血栓形成的炎症过程有着内在的联系.
- *代谢微环境是癌症相关血栓形成的重要危险因素.
- * 抗炎症策略有希望,但需要了解它们的代谢联系.
结论:
- *代谢和炎症之间的协同作用是静脉血栓形成的关键驱动因素.
- * 准代谢和炎症途径是一个有前途的治疗途径.
- *需要进一步的研究来优化抗炎和代谢干预措施,以减少血栓形成风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Venous Return
3.3K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
3.3K
Clot Retraction and Fibrinolysis
4.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.8K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


